Email Updates

You are here

17 APRIL 2020 VOLUME 22 ISSUE 15

Media Coverage

  • On April 18, many of the nation’s health professionals and transgender men and women will recognize National Transgender HIV Testing Day to promote “the importance of routine HIV testing, status awareness and continued focus on HIV prevention and treatment efforts among transgender and gender non-binary people,” according to

    April 17, 2020
  • A Chicago hospital treating severe COVID-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned.

    April 16, 2020
    STAT News
  • Around the turn of the century, developing countries, led by African countries, dramatically fought for and won safeguards to promote access to medicines in international trade law. These safeguards are now being heralded by lawmakers around the world as critical legal mechanisms that nations can and must use in the fight against COVID-19.

    April 16, 2020
    Daily Maverick
  • The World Health Organisation (WHO) said the United States (US) contributed half of the continent’s funding annually and if it withdrew its aid programmes such polio eradication and HIV would suffer.

    April 16, 2020
    Eyewitness News
  • While policy makers may have decided that HIV treatment should be offered without delay to everyone who tests HIV-positive, individual patients may have other priorities and may need time before committing to antiretroviral therapy (ART), Dr Shona Horter of the London School of Hygiene and Tropical Medicine and colleagues warn in Medical Anthropology and in two other recently published articles.

    April 16, 2020
  • How many people living with HIV have acquired the new coronavirus? Are HIV-positive people more—or less—likely to develop severe COVID-19? Can antiretroviral medications for HIV prevent or treat COVID-19? These are among the many unanswered questions researchers are asking about the new coronavirus (officially known as SARS-CoV-2) and its impact on people with HIV.

    April 16, 2020
  • If Mwanyika Thomas had a choice, she would lock herself inside her small home and not venture outside at all. "I have to leave my house to get money for food. But if I didn't have to, I would never leave," the 48-year-old said. "I'm very scared of this virus," she added, referring to the coronavirus disease (COVID-19) pandemic that has swept across the globe.

    April 13, 2020
    Al Jazeera
  • A vaccine for COVID-19 has entered Phase 1 of clinical trials in Seattle. How was it made? And how likely is it that this vaccine, or any others, will work against the new coronavirus? Science journalist and video producer Anna Rothschild spoke with Dr. John Mascola, the director of the Vaccine Research Center at the National Institutes of Health, which co-created the vaccine being tested, along with Moderna Inc.

    April 10, 2020
  • With the world's largest HIV-positive population, SA is moving to protect this particularly vulnerable group from the coronavirus.

    April 9, 2020
    Business Day
  • As the US enters the worst of the COVID-19 health crisis, brick-and-mortar medical practices are learning how to quickly shift non-essential appointments online. These practices are relying on telehealth to minimize in-person interactions, and the theory is, even if labs are required, eliminating person-to-person interaction in the office can help prevent the spread of COVID-19. But in many cases, the learning curve for clinics and doctor’s offices is steep.

    April 7, 2020
    The BodyPro
  • HIV clinics in rural communities face an array of difficulties, from transportation to staffing. Central among these challenges is also the fact that experienced HIV clinicians disproportionately practice in metropolitan areas.

    April 3, 2020
    Contagion Live

Published Research